For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
14
views
0
references
 Top references
cited by
93
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.

      Author(s):
      Publication date:
      Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
      Publisher: Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients with severe asthma are often inadequately controlled on existing anti-asthma therapy, constituting an unmet clinical need.

          Related collections

          Author and article information

          Journal
          PubMed ID:: 15080818
          DOI:: 10.1111/j.1365-2222.2004.1916.x

          Data availability:

          Comments

          Comment on this article

          scite_